000 | 01819 a2200469 4500 | ||
---|---|---|---|
005 | 20250515052223.0 | ||
264 | 0 | _c20070313 | |
008 | 200703s 0 0 eng d | ||
022 | _a1049-3867 | ||
024 | 7 |
_a10.1016/j.whi.2006.09.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatson, Kathleen C | |
245 | 0 | 0 |
_aAssociations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities. _h[electronic resource] |
260 |
_bWomen's health issues : official publication of the Jacobs Institute of Women's Health _c |
||
300 |
_a346-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
650 | 0 | 4 | _aConfidence Intervals |
650 | 0 | 4 |
_aContraceptive Agents, Female _xadverse effects |
650 | 0 | 4 |
_aDelayed-Action Preparations _xadverse effects |
650 | 0 | 4 |
_aPersons with Disabilities _xstatistics & numerical data |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFractures, Spontaneous _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMedicaid |
650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aOsteoporosis _xepidemiology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aWashington _xepidemiology |
650 | 0 | 4 | _aWomen's Health |
700 | 1 | _aLentz, Martha J | |
700 | 1 | _aCain, Kevin C | |
773 | 0 |
_tWomen's health issues : official publication of the Jacobs Institute of Women's Health _gvol. 16 _gno. 6 _gp. 346-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.whi.2006.09.003 _zAvailable from publisher's website |
999 |
_c16755544 _d16755544 |